凝血因子IXa与促凝血血小板的结合被重新检查:与其他因子的低亲和力和相互作用
Polina A Soloveva1, Nadezhda A Podoplelova2, Mikhail A Panteleev3
1Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences, Moscow, 109029, Russia; Department of Biological and Medical Physics, Moscow Institute of Physics and Technology, Dolgoprudny, 141700, Russia.
激活的因子IX (fIXa) 通过类似于脂囊泡的低亲和度位点与血小板结合. 第八因子增强了这种结合,而fIXa,fIX和前热血素也通过新的膜相互作用来调节它.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 激活的因子IX (fIXa) 结合到表达脂的血小板对于血液凝结和内在张力酶复合体组合至关重要.
- 对于fIXa在血小板前凝固剂上的结合点的确切性质和特征仍然不完全理解.
研究的目的:
- 量化描述fIXa在血小板前凝的结合部位.
- 调查影响fIXa结合的因素,包括血小板激活方法和其他凝固因素.
主要方法:
- 使用流细胞计分析了光标记的fIXa与凝过的激活血小板的结合.
- 确定了定量参数,如最大结合位数和解离常数 (Kd).
主要成果:
- fIXa 仅与前凝性血小板亚群结合,其参数与脂囊泡相似 (58,900 ± 3,400 位,Kd = 1000 ± 170 nM).
- 没有确定任何特定的高亲和度结合点,并且结合在各种血小板激活方法中是一致的.
- 第八因子显著增强了FIXa的结合,而X因子仅表现出具有竞争力的效应.
- 意想不到的是,在较低度下,fIXa,fIX和前激素增强了fIXa的结合,这表明二聚体和复合体的形成.
结论:
- 血小板表面提供低亲和度的fIXa的结合点,类似于人造膜.
- 第八因子是fIXa结合的关键增强剂,以前未被识别的涉及fIXa,fIX和前激素的膜相互作用调节了结合.
- 这些发现为血液凝固在血小板表面的分子机制提供了新的见解.
更多相关视频
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
04:32A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
